Dashboard
Discussions
Watchlists
Collections
More
Events
Tools
SIGN UP
SIGN IN
ENTITY
Celltrion Inc (068270 KS)
Watchlist
407
Analysis
Health Care
•
South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Watchlist
All
Insights
Broker Reports
Sponsored
Refresh
Focused
Relevant
bullish
•
Celltrion Inc
•
04 Dec 2023 17:56
Alpha Generation Through Share Buybacks in Korea: October & November 2023
In this insight, we discuss the alpha generation through companies that announced share buybacks in Korea in October and November 2023.
Douglas Kim
78 Views
Share
bullish
•
Celltrion Inc
•
15 Nov 2023 01:12
Progress of Merger Between Celltrion Inc and Celltrion Healthcare & Appraisal Rights Issue
On 14 November, Celltrion Inc announced the total amount of stock purchase rights exercised in the merger of Celltrion Inc and Celltrion Healthcare...
Douglas Kim
808 Views
Share
bullish
•
Celltrion Inc
•
11 Nov 2023 15:07
Celltrion (068270 KS): Record High Revenue and Operating Profit in 3Q23 Solidify Merger Stance
in 3Q23, Celltrion reported sales and op. profit of KRW672B (+4% YoY) and KRW268B (+25% YoY), respectively. Op. profit margin is at 2 year high....
Tina Banerjee
429 Views
Share
bullish
•
Celltrion Inc
•
02 Nov 2023 05:40
Celltrion Merger: Appraisal Rights & Passive Flows
The appraisal rights exercise period ends 13 Nov. Both companies are buying back shares. The last traded price is close to the appraisal price....
Brian Freitas
403 Views
Share
bullish
•
Celltrion Inc
•
24 Oct 2023 10:13
Celltrion Merger: Index Implications
Celltrion Inc (068270 KS) and Celltrion Healthcare (091990 KS) shareholders have approved the merger. The last trading day is expected to be 28...
Brian Freitas
1k Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.23.1
x